Indian Pharmacopoeia should be recognised internationally for exporters: FPME
The Federation of Pharmaceutical Merchant Exporters and Allied Products (FPME) wanted the Central government to take initiatives to make Indian Pharmacopoeia to be recognised internationally for exporters and it should be made part of every trade agreement with independent country
Industrial talks | 06/10/2021 | By Darshana | 209
Syntegon to showcase robotics and automation solutions at PACK EXPO 2021
Syntegon Technology presents its latest processing and packaging solutions at PACK EXPO in Las Vegas from September 27 to 29, 2021. The focus of booth C-2800 is on intelligent robotics and automation technologies. Two automated lines and a series of live presentations offer visitors insights into Syntegon's equipment and service portfolio
Industrial talks | 24/09/2021 | By Darshana | 231
Acute shortage of equipments faced by pharma cos: Infomerics
The report reveals that the steep 50 per cent rise in the cost of active pharmaceutical ingredients (API) is pinching the industry hard and raises doubts on the availability of drugs and could lead to shortages, particularly of those that are key in Covid therapy
Industrial talks | 31/08/2021 | By Darshana | 600
Vivera Pharma's ZICOH technology receives second US patent for smart inhaler device
Vivera Pharmaceuticals, an innovative, science-driven pharmaceutical company located in Southern California, has announced that the US Patent and Trademark Office (USPTO) has granted its ZICOH technology a second US Patent, No. 11,090,449
Industrial talks | 30/08/2021 | By Darshana | 292
Indian vaccine manufacturers face a crucial shortage of equipment including small- and large-scale bioreactors and fermenters, a report "Pharma Industry: Trends and Prospects" from Infomerics Valuation and Rating revealed
Industrial talks | 30/08/2021 | By Darshana | 216
J B Chemicals & Pharmaceuticals stated that it will continue investing and strengthening portfolio in the cardiology and hypertension space and will continue to launch products in the area of anti-allergy, oral corticosteroids, cough & cold and nicotine replacement therapies
Industrial talks | 30/08/2021 | By Darshana | 571
Wockhardt arm partners with Jemincare for novel respiratory antibiotic nafithromycin
Wockhardt Bio AG - a subsidiary of Wockhardt Limited, a worldwide leader in discovery of novel antibiotics and Jiangxi Jemincare Group Company Limited, China, have partnered for Wockhardt's novel patented antibiotic WCK 4873 (nafithromycin) in People's Republic of China, Hong Kong, Macau and Taiwan for the treatment of community-acquired bacterial
Industrial talks | 26/08/2021 | By Darshana | 435
Vertex Pharma, Arbor enter new collaboration to develop novel ex vivo engineered cell therapies
Vertex Pharmaceuticals Incorporated, a global biotechnology company, and Arbor Biotechnologies (Arbor), an early-stage life sciences company, announced a new collaboration to enhance efforts in developing ex vivo engineered cell therapies, using Arbor's proprietary CRISPR gene-editing technology for select diseases
Industrial talks | 25/08/2021 | By Darshana | 377
FPME: Pharma exporters ignored under chapter 29 and 30 for RoDTEP rates
The Federation of Pharmaceutical Merchant Exporters and Allied Products (FPME) stated that pharmaceutical exporters are feeling neglected and taken for granted under Remission of Duties and Taxes on Exported Products (RoDTEP), as no rates were announced under chapter 29 and 30 by the Directorate General of Foreign Trade (DGFT)
Industrial talks | 24/08/2021 | By Darshana | 464
Serum Institute picks up 50% in glass vial maker Schott's Indian JV
Vaccine maker Serum Institute of India (SII) has picked up a 50 per cent stake in specialty glass company Schott AG's Indian joint venture, Schott Kaisha, from the former co-owners Kairus Dadachanji and Shapoor Mistry for an undisclosed sum
Industrial talks | 21/08/2021 | By Darshana | 661
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy